<!DOCTYPE html>
<html>
  <head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<meta http-equiv="X-UA-Compatible" content="chrome=1,IE=edge" />
	<title>bicartial</title>
	<style>
		html {
			height:100%;
		}
		body {
			background-color:#FFFFFF;
			margin:0;
			height:100%;
		}
	</style>
	<!-- copy these lines to your document head: -->

	<meta name="viewport" content="user-scalable=yes, width=1024" />

	<!-- end copy -->
  </head>
  <body>
	<!-- copy these lines to your document: -->

	<div id="bicartial_hype_container" style="margin:auto;position:relative;width:1024px;height:718px;overflow:hidden;" aria-live="polite">
		<script type="text/javascript" charset="utf-8" src="js/bicartial_hype_generated_script.js"></script>
	</div>

	<!-- end copy -->
	


	<!-- text content for search engines: -->

	<div style="display:none">

		<div>1. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., et al. (2012). Heart disease and stroke 2012 update. A report from the American Heart Association. Circulation, 125, e2-e220
2. Rosas Peralta, M., Pastelín Hernández, G., Velázquez Monroy, O., Martínez Reding, J., et al. (2005). Re–encuesta Nacional de Hipertensión Arterial (RENAHTA): Consolidación Mexicana de los Factores de Riesgo Cardiovascular Cohorte Nacional de Seguimiento. Archivos de Cardiología de México, 75, 96-111.
</div>
		<div></div>
		<div>3. Gradman, A. H., Basile, J. N., Carter, B. L., Bakris, G. L. and on behalf of the American Society of Hypertension Writing Group (2011). Combination Therapy in Hypertension. The Journal of Clinical Hypertension, 13, 146–154. 
</div>
		<div>6. Mancia, G., Fagard, R., Narkiewicz, K., et al. (2013). 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Pressure, 22, 193–278.
7. Rubio-Guerra, A. F., Castro-Serna, D., Barrera, C. I. E., & Ramos-Brizuela, L. M. (2009). Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors. Integrated Blood Pressure Control, 2, 55–62.
</div>
		<div>4. Mancia, G., et al., and the ESH-ESC Task Force on the Management of Arterial Hypertension (2007). 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension. Journal of Hypertension, 25, 1105–1187.
5. James, P.A., Oparil, S., Carter, B.L., et al. (2014). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311, 507-520.
</div>
		<div>8. Kohlmann, O. Jr., Oigman, W., Mion, D. Jr., Rocha, J.C., Rocha, J.C., et al. (2006). The "LOTHAR" study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension. Arquivos Brasileiros de Cardiologia, 86, 39-51. (Artículo en portugués).
</div>
		<div>3. Gradman, A. H., Basile, J. N., Carter, B. L., Bakris, G. L. and on behalf of the American Society of Hypertension Writing Group (2011). Combination Therapy in Hypertension. The Journal of Clinical Hypertension, 13, 146–154. 
</div>
		<div>9. Durán-Salgado, M.B., Garro-Almendaro, A.K., Rubio-Guerra, A.F. (2015). Cambios metabólicos ocasionados por las combinaciones de losartán con hidroclorotiazida o con amlodipino en pacientes hipertensos. Medicina Interna de México, 31, 395-401.
</div>
		<div>8. Kohlmann, O. Jr., Oigman, W., Mion, D. Jr., Rocha, J.C., Rocha, J.C., et al. (2006). The "LOTHAR" study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension. Arquivos Brasileiros de Cardiologia, 86, 39-51. (Artículo en portugués).
9. Durán-Salgado, M.B., Garro-Almendaro, A.K., Rubio-Guerra, A.F. (2015). Cambios metabólicos ocasionados por las combinaciones de losartán con hidroclorotiazida o con amlodipino en pacientes hipertensos. Medicina Interna de México, 31, 395-401.10. Corrao, G., Nicotra, F., Parodi, A., Zambon, A., Heiman, F., et al. (2011). Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice. Hypertension, 58, 566-572
11. Hamada, T., Ichida, K., Hosoyamada, M., Mizuta, E., Yanagihara, K., Sonoyama, K., et al. (2008). Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients. American Journal of Hypertension, 21, 1157-1162.
</div>

	</div>

	<!-- end text content: -->

  </body>
</html>
